FDA Adverse Event Injury Summary report: N

ACRYSOF

MDR report key: 2992518 · Received March 4, 2013

Report

Report Number
1119421-2013-00211
Event Type
Injury
Date Received
March 4, 2013
Date of Event
November 1, 2012
Report Date
February 4, 2013
Manufacturer
ALCON RESEARCH, LTD. / HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVAL SUMMARY: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THE ROOT CAUSE FOR THE REPORTED COMPLAINT COULD NOT BE DETERMINED AS NO PRODUCT WAS RETURNED FOR ANALYSIS. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDITIONAL INFO. MEDICAL RECORDS WERE RECEIVED ON (B)(4) 2013. THE SURGEON WAS UNWILLING TO COMPLETE THE QUESTIONNAIRE. (B)(4).

Description of Event or Problem · 1

A SURGEON ORIGINALLY REPORTED THAT ABOUT FIFTEEN OF HER PTS HAD TO HAVE EARLY YAG CAPSULOTOMY DUE TO HAZING ON THE ANTERIOR SURFACE OF THE LENS FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT SURGERY. SOME CASES WERE WORSE THAN OTHERS, AND ALL OCCURRED WITHIN THE PAST FOUR MONTHS. THE PTS WERE NOTED TO BE DOING WELL POSTOPERATIVELY. MEDICAL RECORDS WERE RECEIVED FROM THE SURGEON FOR NINE PTS. FOR THIS PT, MEDICAL RECORDS FROM THE FIRST POSTOPERATIVE DAY ONLY WERE RECEIVED WHICH SHOWED THE PT DOING WELL. THE PT REPORTED SOME PAIN FOR A FEW HOURS FOLLOWING HER IOL IMPLANT THAT HAD IMPROVED BY THE FIRST POSTOPERATIVE DAY. THE PT WAS BILATERALLY IMPLANTED. THERE ARE TWELVE MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THE MDR FOR THE FOUR REMAINING UNK PTS WAS FILED UNDER MFR REPORT NUMBER 1119421-2012-01555. THIS FILE IS FOR THE THIRD PT, RIGHT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
91637 ACRYSOF INTRAOCULAR LENS HQL ALCON RESEARCH, LTD. / HUNTINGTON SN60WF 12184565

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention